PHOTO
Regional MedTech trade association Mecomed led a vital discussion on the future of the MEA healthcare sector at this year’s Arab Health event, urging industry professionals and other healthcare stakeholders to focus on patient-centered care.
In a session called “Shaping the MedTech Industry, while keeping the patient first”, Mecomed called for patient welfare to be at the center of all healthcare strategies, and unveiled a three-pronged strategy for doing so. By bringing patient-centered care into regulations, establishing high compliance standards, and instilling value-based thinking, Mecomed showed how treatment outcomes, information flow and quality of care could be elevated across the region.
The talk was led by Mecomed Chairman, Rami Rajab, and the association’s Executive Director, Inna Nadelwais. They unveiled insights from Mecomed’s White Paper on “Value-based Healthcare in the Middle East and Africa”, with Nadelwais shedding light on how the industry can engage into the innovative value-based delivery models. She also called for regional organizations to restructure their processes to reward value and stressed the critical roles leadership and medical technology are playing in accelerating this transformation.
“Rising costs and continually evolving regulations are putting regional healthcare providers under extraordinary pressure as they try to improve patient outcomes,” said Rajab. “By adopting a value-based healthcare model, the industry can start to overcome the challenges that stand in the way of better patient care, and drive an evolution in practices that will allow a stronger, more agile industry to take shape. In so doing, the region can optimize treatment outcomes and lead the world in patient-centered care.”
Arab Health 2020 took place amid a significant growth spike for the Middle East and North Africa (MENA) healthcare sector. Projections by Fitch Solutions suggest that the regional healthcare market will grow from US$ 185.5 billion in 2019 to US$ 243.6 billion in 2023 – a compound annual growth rate (CAGR) of 7.05%. More than 4,250 companies from some 160 countries exhibited at this year's event, which welcomed around 55,000 healthcare and trade professionals.
Mecomed is the trade association for medical technology companies across the Middle East and Africa (MEA), serving as the voice of Medical Technology industry. The association also works closely with MEA healthcare officials to establish credible healthcare standards for the region.
Also at the networking event, Mecomed elaborated on key projects for 2020 and shared its strategy for 2020-2025 that included among other initiatives establishing the organisation as partner of choice across MEA; continuing the development of local ethical codes across the region; growing its membership base to 100 in five years; and helping shape regional legislation affecting Medical Technology industry.
© Press Release 2020Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
